Equine Vaccines & Innovative Healthcare for Horses
Treating chronic diseases such as allergies and respiratory diseases.
Evax develops new equine vaccines for the treatment of chronic diseases, allergies and respiratory diseases.
For many equine diseases only limited therapeutic treatment options are available with sometimes poor efficacy. Hence, there is a major need for new, innovative, specific and efficacious equine therapeutics. Our mission is to transfer human standards of care into horses at an affordable price.
Our first therapy candidate is a vaccine for summer eczema.
Summer eczema, also called sweet itch or insect bite hypersensitivity (IBH) is the most prevalent allergic skin disease in horses. It manifests as chronic relapsing seasonal allergic dermatitis (inflammatory reaction of the skin).
Although IBH is the best studied and characterized allergic disease of horses, treatment options are still poor and not even close to satisfactory. Our vision is to end this suffering, developing a vaccine that therapeutically treats and prophylactically prevents summer eczema.
Caring for Research
With every purchase of our care products for horses you support the further development of effective therapies for chronic diseases, allergies and respiratory diseases in horses.
The founder of Evax
Dr. Antonia Gabriel (Fettelschoss)
She started riding at the age of 5 and got to know Icelandic horses at the age of 12 and remains loyal to them to this day. Her family has since owned Icelandic horses, all of which were imports from Iceland and affected by sweet itch.
Do you have a question?
Get to know the Evax team
We collaborate with
